GlassScriptPhysician profile
Jazmine Rojas
NPI 1104555176
$2,946.26
in general payments reported to CMS, 2019-2025
9 companies · $525 in 2025
The $525 reported for 2025 was more than what 78% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $645 · 2023: $1,094 · 2024: $682 · 2025: $525.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,301.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,301.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Vision Care, INC. | $882.36 | 2023-2025 | Acuvue |
| Bausch & Lomb Americas INC. | $813.70 | 2022-2024 | Infuse |
| Alcon Vision LLC | $661.32 | 2022-2025 | Precision7, Total30, Dailies Total1 |
| Coopervision INC. | $220.94 | 2023-2024 | Myday Contact Lens, Misight Contact Lens |
| Horizon Therapeutics Plc | $124.99 | 2022 | |
| Optos, INC. | $87.41 | 2022 | |
| Topcon Healthcare, INC. | $60.58 | 2023 | |
| Oyster Point Pharma, INC. | $48.08 | 2024 | Tyrvaya |
| Visionix USA, INC | $46.88 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jazmine Rojas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.